Simulations Plus, Inc. (NASDAQ:SLP) Director Walter S. Woltosz Sells 20,000 Shares

Simulations Plus, Inc. (NASDAQ:SLP) Director Walter S. Woltosz sold 20,000 shares of the company’s stock in a transaction dated Wednesday, May 1st. The stock was sold at an average price of $45.95, for a total transaction of $919,000.00. Following the transaction, the director now owns 3,580,857 shares in the company, valued at approximately $164,540,379.15. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Simulations Plus Trading Up 0.9 %

NASDAQ:SLP opened at $46.72 on Friday. Simulations Plus, Inc. has a 1-year low of $32.69 and a 1-year high of $52.69. The firm has a fifty day simple moving average of $43.93 and a 200 day simple moving average of $41.14. The stock has a market capitalization of $933.93 million, a PE ratio of 88.15 and a beta of 0.68.

Simulations Plus (NASDAQ:SLP) last announced its quarterly earnings results on Wednesday, April 3rd. The technology company reported $0.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.18 by $0.02. Simulations Plus had a return on equity of 7.95% and a net margin of 16.22%. The business had revenue of $18.31 million during the quarter, compared to the consensus estimate of $17.31 million. During the same quarter last year, the firm posted $0.20 EPS. The company’s quarterly revenue was up 16.2% on a year-over-year basis. On average, equities analysts predict that Simulations Plus, Inc. will post 0.67 earnings per share for the current fiscal year.

Simulations Plus Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, May 6th. Shareholders of record on Monday, April 29th will be given a $0.06 dividend. This represents a $0.24 dividend on an annualized basis and a yield of 0.51%. The ex-dividend date of this dividend is Friday, April 26th. Simulations Plus’s dividend payout ratio is presently 45.28%.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Connecticut Wealth Management LLC bought a new position in shares of Simulations Plus during the 1st quarter worth approximately $204,000. Janney Montgomery Scott LLC purchased a new stake in shares of Simulations Plus during the 1st quarter valued at $208,000. BNP Paribas Financial Markets increased its position in shares of Simulations Plus by 9.1% during the 1st quarter. BNP Paribas Financial Markets now owns 14,143 shares of the technology company’s stock valued at $582,000 after purchasing an additional 1,174 shares during the last quarter. Allspring Global Investments Holdings LLC purchased a new stake in Simulations Plus in the 1st quarter worth about $70,000. Finally, Principal Financial Group Inc. increased its holdings in Simulations Plus by 1.4% in the 1st quarter. Principal Financial Group Inc. now owns 88,142 shares of the technology company’s stock worth $3,627,000 after acquiring an additional 1,203 shares during the last quarter. Institutional investors and hedge funds own 78.08% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Craig Hallum upped their target price on shares of Simulations Plus from $50.00 to $51.00 and gave the company a “buy” rating in a research report on Thursday, January 4th.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.